BIA forms synthetic biology working group – Biosyntha is a founder member

Eight synthetic biology (synbio) companies have joined the BioIndustry Association (BIA) to form a new group working on this emerging area of bioscience.

Synbio is the design and engineering of biologically based parts, novel devices and systems as well as the redesign of existing, natural biological systems. It has the potential to deliver important new applications and improve existing industrial processes – resulting in economic growth and job creation.

The eight companies founding the BIA synbio group are: Algenuity, Biosyntha, Genabler, Green Biologics, Oxitec, Prokarium, Synpromics and Synthace.

Lionel Clarke, Chairman of the UK Synbio Leadership Council said:

“I am extremely pleased to see that the Roadmap is already delivering such a positive impact – raising the profile of Synthetic Biology companies within the UK, and galvanising action aligned with our vision.   This will provide a valuable forum for bringing together and representing the ongoing interests of this rapidly developing industrial community.”

For the full press release click here